Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a Patient With Intellectual Developmental Disorder, Autosomal Dominant 7

Por um escritor misterioso
Last updated 16 junho 2024
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Intellectual developmental disorder, autosomal dominant 7 (MRD7; OMIM 614104) is a rare disease characterized by microcephaly, intellectual disability, speech delay, feeding difficulties, and facial dysmorphisms. This disorder is caused by pathogenic/likely pathogenic variants of the DYRK1A gene, which encodes dual-specificity tyrosine-phosphorylation-regulated kinase 1A. Here, we report a case of MRD7 that was diagnosed using Face2Gene and whole-exome sequencing (WES). A 22-year-old man presented with microcephaly, intellectual disability, slender body, long slender fingers, and facial dysmorphisms. He was previously diagnosed with Cornelia de Lange syndrome (CdLS) at four years of age. However, his CdLS clinical diagnostic score was low at 22 years of age. The Face2Gene application introduced several candidate diseases including MRD7. Finally, by utilizing WES and Sanger sequencing analysis of cloned cDNA, we identified a novel heterozygous duplication variant (c.848dup, p.(Asn283LysfsTer6)) in the DYRK1A gene, which introduces a premature stop codon. This report provides more information about the phenotypic spectrum of a young adult patient with MRD7. Face2Gene helped us introduce candidate diseases of the patient. Registering further genetically confirmed cases with MRD7 will improve the accuracy of the diagnostic recommendations in Face2Gene. Moreover, WES is a powerful tool for diagnosing rare genetic diseases, such as MRD7.
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Rare-disease genetics in the era of next-generation sequencing: discovery to translation
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
PDF) Neurodevelopmental Disorder, Obesity, Pancytopenia, Diabetes Mellitus, Cirrhosis, and Renal Failure in ACBD6 -Associated Syndrome: A Case Report
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Whole exome sequencing identifies a novel intron heterozygous mutation in TSC2 responsible for tuberous sclerosis complex
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Pitfalls of whole exome sequencing in undefined clinical conditions with a suspected genetic etiology
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Frontiers Case report: A novel de novo deletion mutation of DYRK1A is associated with intellectual developmental disorder, autosomal dominant 7
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Frontiers Whole exome sequencing identified five novel variants in CNTN2, CARS2, ARSA, and CLCN4 leading to epilepsy in consanguineous families
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Genetic diagnosis of Mendelian disorders via RNA sequencing
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Whole exome sequencing identifies novel DYT1 dystonia-associated genome variants as potential disease modifiers
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
The contribution of whole-exome sequencing to intellectual disability diagnosis and knowledge of underlying molecular mechanisms: A systematic review and meta-analysis - ScienceDirect
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Targeting epigenetics: A novel promise for Alzheimer's disease treatment - ScienceDirect
Cureus, Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a  Patient With Intellectual Developmental Disorder, Autosomal Dominant 7
Autosomal recessive mutations in THOC6 cause intellectual disability: syndrome delineation requiring forward and reverse phenotyping - Amos - 2017 - Clinical Genetics - Wiley Online Library

© 2014-2024 jeart-turkiye.com. All rights reserved.